Biotech & Medtech
Biotech & Medtech news — Sunday 25 October 2026
7 stories from 2 sources, every one in English. Each links to its publisher.
-
CareValidate Launches Expanded HRT Offering
MedCity News
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination. The post CareValidate Launches Expanded HRT Offering appeared first on…
-
STAT+: At ESMO, AstraZeneca’s cancer pursuits get a showcase
STAT News
MADRID — For AstraZeneca, a major oncology conference here this weekend has been a sign of how the company’s cancer work is steamrolling ahead, with highlights from a mix of old standbys and new molecules that could expand its armament of…
-
Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science
MedCity News
Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against…
-
Congress’s Patient Matching Fix Won’t Work — Here’s What Would
MedCity News
The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution. The post Congress’s Patient Matching Fix Won’t Work — Here’s What Would appeared first on MedCity News .
-
Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR
MedCity News
In most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open…
-
Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow
MedCity News
Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive…
-
STAT+: After a cancer vaccine’s first success, the race is on to expand the impact
STAT News
MADRID — With the first pivotal trial showing a customized mRNA treatment improved outcomes for cancer patients presented here this weekend, the conversation has already turned to how melanoma specialists should adopt the medicine — and…